Shigemitsu Ohsawa

Title: Shigemitsu Ohsawa: Innovator in Pharmaceutical Preparations

Introduction

Shigemitsu Ohsawa is a notable inventor based in Honjou, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative preparations that enhance drug stability and absorption. With a total of 4 patents to his name, Ohsawa's work has had a meaningful impact on the industry.

Latest Patents

Ohsawa's latest patents include methods employing stable preparations containing azelastine hydrochloride. This innovative composition combines azelastine hydrochloride with certain fatty acids, enhancing both the stability and absorbability of the formulation. Another significant patent involves a pharmaceutical preparation for percutaneous administration, which comprises eperisone or tolperisone, including their salts, along with a monoglyceride of an aliphatic acid having 8 to 12 carbon atoms or an ester of lactic acid with an aliphatic alcohol having 12 to 18 carbon atoms. This preparation is designed to improve percutaneous absorption, showcasing Ohsawa's commitment to advancing pharmaceutical technology.

Career Highlights

Throughout his career, Shigemitsu Ohsawa has worked with prominent companies such as Eisai Company, Limited and Sansho Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in the pharmaceutical sector.

Collaborations

Ohsawa has collaborated with esteemed colleagues, including Yutaka Morita and Mitsuhiro Yoshida. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of innovative solutions.

Conclusion

Shigemitsu Ohsawa's contributions to pharmaceutical preparations demonstrate his dedication to innovation and improvement in drug delivery systems. His patents reflect a deep understanding of the complexities involved in pharmaceutical formulations, making him a valuable figure in the industry.